The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury

Bin Zhang, Wei Shi, Juan Ma, Alexis Sloan, Christian H Faul, Changli Wei, Jochen Reiser, Yun Yang, Shuangxin Liu, Wenjian Wang

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Circulating and podocyte-bound urokinase receptor (uPAR) is a mediator of podocyte injury, proteinuria, and focal segmental glomerulosclerosis (FSGS) allowing pathological activation of the uPAR-β3 integrin signaling axis. Clinically, calcineurin inhibitors (e.g., cyclosporine A, CsA) are known to suppress T cells, yet are also being used to reduce proteinuria in FSGS, suggesting the possibility of signal cross talk between uPAR and calcineurin. Calcineurin is known to facilitate the nuclear translocation of the nuclear factor of activated T cells (NFAT). Accordingly, in vivo conditional NFATc1 activation in podocytes leads to proteinuria in mice, yet the downstream targets of NFAT remain unclear. Here, we show that inducible podocyte-specific expression of constitutively active NFATc1 increased podocyte uPAR expression by binding to the Plaur gene promoter (encoding uPAR) in chromatin immunoprecipitation assays. Pathological uPAR signals in podocytes are independent of T cells and affect cell motility via activation, but not expression, changes of the β3 integrin and can be blocked by CsA, NFAT-siRNA, or the cell-permeable NFAT inhibitor (11R-VIVIT) using rodent models of glomerular disease (LPS; 5/6 nephrectomized rats). Taken together, these findings identify podocyte uPAR as a downstream target of NFAT and provide further insights into the pathogenesis of FSGS.

Original languageEnglish
Pages (from-to)1407-1420
Number of pages14
JournalJournal of Molecular Medicine
Volume90
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

NFATC Transcription Factors
Integrin beta3
Podocytes
Calcineurin
Urokinase-Type Plasminogen Activator
Focal Segmental Glomerulosclerosis
Wounds and Injuries
Proteinuria
Integrins
Cyclosporine
T-Lymphocytes
Chromatin Immunoprecipitation
Small Interfering RNA
Cell Movement
Rodentia

Keywords

  • β3 integrin
  • Calcineurin
  • NFAT
  • Podocyte
  • suPAR
  • uPAR

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Genetics(clinical)

Cite this

The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. / Zhang, Bin; Shi, Wei; Ma, Juan; Sloan, Alexis; Faul, Christian H; Wei, Changli; Reiser, Jochen; Yang, Yun; Liu, Shuangxin; Wang, Wenjian.

In: Journal of Molecular Medicine, Vol. 90, No. 12, 01.12.2012, p. 1407-1420.

Research output: Contribution to journalArticle

Zhang, B, Shi, W, Ma, J, Sloan, A, Faul, CH, Wei, C, Reiser, J, Yang, Y, Liu, S & Wang, W 2012, 'The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury', Journal of Molecular Medicine, vol. 90, no. 12, pp. 1407-1420. https://doi.org/10.1007/s00109-012-0960-6
Zhang, Bin ; Shi, Wei ; Ma, Juan ; Sloan, Alexis ; Faul, Christian H ; Wei, Changli ; Reiser, Jochen ; Yang, Yun ; Liu, Shuangxin ; Wang, Wenjian. / The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. In: Journal of Molecular Medicine. 2012 ; Vol. 90, No. 12. pp. 1407-1420.
@article{447ba9bc090b445c9aaab3b4f1e2f5b9,
title = "The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury",
abstract = "Circulating and podocyte-bound urokinase receptor (uPAR) is a mediator of podocyte injury, proteinuria, and focal segmental glomerulosclerosis (FSGS) allowing pathological activation of the uPAR-β3 integrin signaling axis. Clinically, calcineurin inhibitors (e.g., cyclosporine A, CsA) are known to suppress T cells, yet are also being used to reduce proteinuria in FSGS, suggesting the possibility of signal cross talk between uPAR and calcineurin. Calcineurin is known to facilitate the nuclear translocation of the nuclear factor of activated T cells (NFAT). Accordingly, in vivo conditional NFATc1 activation in podocytes leads to proteinuria in mice, yet the downstream targets of NFAT remain unclear. Here, we show that inducible podocyte-specific expression of constitutively active NFATc1 increased podocyte uPAR expression by binding to the Plaur gene promoter (encoding uPAR) in chromatin immunoprecipitation assays. Pathological uPAR signals in podocytes are independent of T cells and affect cell motility via activation, but not expression, changes of the β3 integrin and can be blocked by CsA, NFAT-siRNA, or the cell-permeable NFAT inhibitor (11R-VIVIT) using rodent models of glomerular disease (LPS; 5/6 nephrectomized rats). Taken together, these findings identify podocyte uPAR as a downstream target of NFAT and provide further insights into the pathogenesis of FSGS.",
keywords = "β3 integrin, Calcineurin, NFAT, Podocyte, suPAR, uPAR",
author = "Bin Zhang and Wei Shi and Juan Ma and Alexis Sloan and Faul, {Christian H} and Changli Wei and Jochen Reiser and Yun Yang and Shuangxin Liu and Wenjian Wang",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s00109-012-0960-6",
language = "English",
volume = "90",
pages = "1407--1420",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury

AU - Zhang, Bin

AU - Shi, Wei

AU - Ma, Juan

AU - Sloan, Alexis

AU - Faul, Christian H

AU - Wei, Changli

AU - Reiser, Jochen

AU - Yang, Yun

AU - Liu, Shuangxin

AU - Wang, Wenjian

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Circulating and podocyte-bound urokinase receptor (uPAR) is a mediator of podocyte injury, proteinuria, and focal segmental glomerulosclerosis (FSGS) allowing pathological activation of the uPAR-β3 integrin signaling axis. Clinically, calcineurin inhibitors (e.g., cyclosporine A, CsA) are known to suppress T cells, yet are also being used to reduce proteinuria in FSGS, suggesting the possibility of signal cross talk between uPAR and calcineurin. Calcineurin is known to facilitate the nuclear translocation of the nuclear factor of activated T cells (NFAT). Accordingly, in vivo conditional NFATc1 activation in podocytes leads to proteinuria in mice, yet the downstream targets of NFAT remain unclear. Here, we show that inducible podocyte-specific expression of constitutively active NFATc1 increased podocyte uPAR expression by binding to the Plaur gene promoter (encoding uPAR) in chromatin immunoprecipitation assays. Pathological uPAR signals in podocytes are independent of T cells and affect cell motility via activation, but not expression, changes of the β3 integrin and can be blocked by CsA, NFAT-siRNA, or the cell-permeable NFAT inhibitor (11R-VIVIT) using rodent models of glomerular disease (LPS; 5/6 nephrectomized rats). Taken together, these findings identify podocyte uPAR as a downstream target of NFAT and provide further insights into the pathogenesis of FSGS.

AB - Circulating and podocyte-bound urokinase receptor (uPAR) is a mediator of podocyte injury, proteinuria, and focal segmental glomerulosclerosis (FSGS) allowing pathological activation of the uPAR-β3 integrin signaling axis. Clinically, calcineurin inhibitors (e.g., cyclosporine A, CsA) are known to suppress T cells, yet are also being used to reduce proteinuria in FSGS, suggesting the possibility of signal cross talk between uPAR and calcineurin. Calcineurin is known to facilitate the nuclear translocation of the nuclear factor of activated T cells (NFAT). Accordingly, in vivo conditional NFATc1 activation in podocytes leads to proteinuria in mice, yet the downstream targets of NFAT remain unclear. Here, we show that inducible podocyte-specific expression of constitutively active NFATc1 increased podocyte uPAR expression by binding to the Plaur gene promoter (encoding uPAR) in chromatin immunoprecipitation assays. Pathological uPAR signals in podocytes are independent of T cells and affect cell motility via activation, but not expression, changes of the β3 integrin and can be blocked by CsA, NFAT-siRNA, or the cell-permeable NFAT inhibitor (11R-VIVIT) using rodent models of glomerular disease (LPS; 5/6 nephrectomized rats). Taken together, these findings identify podocyte uPAR as a downstream target of NFAT and provide further insights into the pathogenesis of FSGS.

KW - β3 integrin

KW - Calcineurin

KW - NFAT

KW - Podocyte

KW - suPAR

KW - uPAR

UR - http://www.scopus.com/inward/record.url?scp=84884211336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884211336&partnerID=8YFLogxK

U2 - 10.1007/s00109-012-0960-6

DO - 10.1007/s00109-012-0960-6

M3 - Article

VL - 90

SP - 1407

EP - 1420

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 12

ER -